Registration - In-house Corporation

Edesa Biotech Research, Inc. / Pardeep Nijhawan, Chief Executive Officer

Registration Information

In-house Corporation name: Edesa Biotech Research, Inc.
Responsible Officer Name: Pardeep Nijhawan, Chief Executive Officer
Initial registration start date: 2020-09-14
Registration status: Active
Registration Number: 947006-367429

Associated Communications

Total Number of Communication Reports: 5

Monthly communication reports in the last 6 months: 0

Version 1 of 11 (2020-09-14 to 2020-09-14)

Registration versions:

Version 1 of 11 (2020-09-14 to 2020-09-14)

Lobbying Information

Subject Matters

Health

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Seeking funding to allow for increased research and development and other expenditures into two clinical-stage antibodies to treat acute respiratory distress syndrome (the primary cause of death from COVID-19) from the Industrial Research Assistance Program and the Strategic Innovation Fund.

Communication Techniques

Written communication
Oral communication

Government Institutions

Innovation, Science and Economic Development Canada (ISED)

In-house Corporation Details

Description of activities

We are a biopharmaceutical company focused on acquiring, developing and commercializing clinical-stage drugs for indications with clear unmet medical needs.

Responsible officer name and position during the period of this registration

Pardeep Nijhawan, Chief Executive Officer

Government funding

End date of the last completed financial year: 2019-09-30

List of Government Funding
Government Institution	Funding Received in Last Financial Year	Funding Expected in Current Financial Year
Global Affairs Canada (GAC)	$5,200.00	No

In-house Corporation Contact Information

Address:
100 Spy Court
Markham, ON L3R 5H6
Canada

Telephone number: 289-800-9600
Fax number: 805-488-2800

Parent Company Information

Edesa Biotech, Inc.
- 100 Spy Court
  Markham, ON L3R 5H6
  Canada

Subsidiary Beneficiary Information

Edesa Biotech Research, Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Michael Brooks, President | No public offices held
Blair Gordon, Vice President, Research and Development | No public offices held
Kathi Niffenegger, Chief Financial Officer | No public offices held
Pardeep Nijhawan, Chief Executive Officer | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

No lobbyists added

Edesa Biotech Research, Inc./

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Edesa Biotech Research, Inc./	2024-03-01	current
Edesa Biotech Research, Inc./	2020-09-14	2024-03-01

Edesa Biotech Research, Inc.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Pardeep Nijhawan, Chief Executive Officer (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-5 of 5

Edesa Biotech Research, Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bianca Hossain, Policy Advisor | Minister's Office | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Research and Development
Communication date: 2023-01-28
Posted date: 2023-10-30
Communication number: 367429-580525 View associated registration
Edesa Biotech Research, Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Nancy Hamzawi, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
Subject Matter of the communication: Health, Research and Development
Communication date: 2022-11-17
Posted date: 2022-12-15
Communication number: 367429-550409 View associated registration
Edesa Biotech Research, Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)
- Jamie Kippen, Chief of Staff | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Health, Research and Development
Communication date: 2022-11-17
Posted date: 2022-12-15
Communication number: 367429-550408 View associated registration
Edesa Biotech Research, Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Eric Costen, Senior Assistant Deputy Minister, Industry Sector | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health
Communication date: 2022-01-28
Posted date: 2022-02-15
Communication number: 367429-522453 (amended from 367429-522395) View associated registration
Edesa Biotech Research, Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sarah Hussaini, Chief of Staff, Minister's Office | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health
Communication date: 2022-01-26
Posted date: 2022-02-15
Communication number: 367429-522455 (amended from 367429-522393) View associated registration

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - In-house Corporation

Edesa Biotech Research, Inc. / Pardeep Nijhawan, Chief Executive Officer

Registration Information

Associated Communications

Version 1 of 11 (2020-09-14 to 2020-09-14)

Version 1 of 11 (2020-09-14 to 2020-09-14)

Subject Matters

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties